Literature DB >> 22378598

[Consensus statement haemorrhoidal disease].

Felix Aigner1, Friedrich Conrad, Ingrid Haunold, Johann Pfeifer, Andreas Salat, Max Wunderlich, Rene Fortelny, Helga Fritsch, Markus Glöckler, Hubert Hauser, Andreas Heuberger, Judith Karner-Hanusch, Christoph Kopf, Peter Lechner, Stefan Riss, Sebastian Roka, Matthias Scheyer.   

Abstract

Haemorrhoidal disease belongs to the most common benign disorders in the lower gastrointestinal tract. Treatment options comprise conservative as well as surgical therapy still being applied arbitrarily in accordance with the surgeon's expertise. The aim of this consensus statement was therefore to assess a stage-dependent approach for treatment of haemorrhoidal disease to derive evidence-based recommendations for clinical routine. The most common methods are discussed with respect of haemorrhoidal disease in extraordinary conditions like pregnancy or inflammatory bowel disease and recurrent haemorrhoids. Tailored haemorrhoidectomy is preferable for individualized treatment with regard to the shortcomings of the traditional Goligher classification in solitary or circular haemorrhoidal prolapses.

Entities:  

Mesh:

Year:  2012        PMID: 22378598     DOI: 10.1007/s00508-011-0107-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  97 in total

1.  The nature of haemorrhoids.

Authors:  W H Thomson
Journal:  Br J Surg       Date:  1975-07       Impact factor: 6.939

2.  Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.

Authors:  Dimitrios Dimitroulopoulos; Klisthenis Tsamakidis; Dimitrios Xinopoulos; Ioannis Karaitianos; Aikaterini Fotopoulou; Emmanouil Paraskevas
Journal:  Clin Ther       Date:  2005-06       Impact factor: 3.393

3.  Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial.

Authors:  Rosalia Patti; Piero Luigi Almasio; Almasio Piero Luigi; Matteo Arcara; Arcara Matteo; Sergio Sammartano; Sammartano Sergio; Pietro Romano; Romano Pietro; Calogero Fede; Fede Calogero; Gaetano Di Vita; Di Vita Gaetano
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

4.  A comparison of quality of life and postoperative results from combined PPH and conventional haemorrhoidectomy in different cases of haemorrhoidal disease.

Authors:  A Martinsons; Z Narbuts; I Brunenieks; M Pavars; S Lebedkovs; J Gardovskis
Journal:  Colorectal Dis       Date:  2007-06       Impact factor: 3.788

5.  Rubber band ligation of hemorrhoids and rectal mucosal prolapse in constipated patients.

Authors:  C Mattana; G Maria; M Pescatori
Journal:  Dis Colon Rectum       Date:  1989-05       Impact factor: 4.585

6.  Primary and repeated stapled hemorrhoidopexy for prolapsing hemorrhoids: follow-up to five years.

Authors:  Dennis Raahave; Lars V Jepsen; Ib K Pedersen
Journal:  Dis Colon Rectum       Date:  2008-01-19       Impact factor: 4.585

Review 7.  Continence disorders after anal surgery--a relevant problem?

Authors:  A Ommer; F A Wenger; T Rolfs; M K Walz
Journal:  Int J Colorectal Dis       Date:  2008-07-16       Impact factor: 2.571

8.  Topical sucralfate decreases pain after hemorrhoidectomy and improves healing: a randomized, blinded, controlled study.

Authors:  P J Gupta; P S Heda; S Kalaskar; V P Tamaskar
Journal:  Dis Colon Rectum       Date:  2007-12-18       Impact factor: 4.585

Review 9.  Haemorrhoids: pathology, pathophysiology and aetiology.

Authors:  P B Loder; M A Kamm; R J Nicholls; R K Phillips
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

10.  Constipation is not a risk factor for hemorrhoids: a case-control study of potential etiological agents.

Authors:  J F Johanson; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

View more
  1 in total

1.  Hemorrhoids and the recurrent attempts to destroy them.

Authors:  Carlo Ratto
Journal:  Tech Coloproctol       Date:  2016-12-20       Impact factor: 3.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.